FDA direct-to-consumer advertising for prescription drugs: What are consumer preferences and response tendencies?

Health Marketing Quarterly

Volumn 24, Issue 1-2, 2008, Pages 77-91

  Khanfar, Nile ^a,c   Loudon, David ^b   Sircar Ramsewak, Feroza ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b SAMFORD UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Consumers; Direct to consumer advertisements; DTC; Help seeking ads; Prescription drug advertising; Product claim ads; Reminder ads

Indexed keywords

ADOLESCENT; ADULT; ADVERTIZING; AGE; AGED; ARTICLE; CONSUMER; DRUG INDUSTRY; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; REMINDER SYSTEM; SEX DIFFERENCE; SOCIOECONOMICS; TELEVISION; UNITED STATES;

ADOLESCENT; ADULT; ADVERTISING AS TOPIC; AGE FACTORS; AGED; CONSUMER SATISFACTION; DRUG INDUSTRY; FEMALE; HUMANS; MALE; MIDDLE AGED; REMINDER SYSTEMS; SEX FACTORS; SOCIOECONOMIC FACTORS; TELEVISION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; YOUNG ADULT;

EID: 66349088502     PISSN: 07359683     EISSN: 15450864     Source Type: Journal    
DOI: 10.1080/07359680802125899     Document Type: Article

References (14)

1. Bell, R., Kravitz, R. & Wilkes, M. Direct to consumer prescription drug advertising and the public. J Gen Intern Med. Nov.14 1999; 651-657
2. Berndt, E.R. To inform or persuade? Direct-to-consumer advertising of prescription drugs. NEnglJ Med. 2005; 352(4):325-28. FDA 2004. http://www.fda.gov/bbs/topics/NEWS/2004/ NEW01016.htlm. Accessed November 10, 2005
3. Clow, K. Integrated Advertising, Promotion, and Marketing Communications, Second Edition. 2004
4. Gareau, P. The impact of direct-to- consumer advertising of prescription medicine on consumer's intention to perform external search. University of Guelph(Canada). 2000
5. IMS Total U. S. promotional spend by type, 2005. http://www.imshealth. com/imsprotal/ front/articleC/O. Accessed June 06, 2006
6. Maddox, M. & Katsanis, L. Direct-to-Consumer Advertising of Prescription Drugs in Canada: Its Potential Effects on Patient-Physician Interaction. JPMM. 1997; 12(1): 1-21
7. Mello, M., Rosenthall, M., and Neumann, P. Direct-to- Consumer Advertising and Shared Liability for Pharmaceutical Manufacturers. JAMA. 2003; 289(4): 477-481
8. Ostrove, N. Department of Health and Human Services Meetings. July 24 2001
9. http://www.the-dma. org. Accessed November 20, 2005
10. Pierpaoli, P. ASHP position on direct- to-consumer advertising of prescription drugs. American Journal of Hospital Pharmacy. 1995; 43: 1763-66. IMS Health Reports Global Pharmaceutical market. http://www.imshealth.com/ imsprotal/front/ar ticleC/O. Accessed June 06, 2006
11. Weissman, J., Bluemnthal, D., Silk, A., Zapert, K., Newman, M. & Leitman, R.(2003). Consumer's reports on the health effects of direct-to-consumer drug advertising. Health Affairs
12. Williams, J. & Hensel, P.(1995). Direct-to-Consumer Advertising of Prescription Drugs. Journal of Health Care Marketing, 15(1), 35
13. Wolfe, S. Direct-to-Consumer Advertising: Education or Emotion Promotion. NEng J Med, 2002; 346(7):524- 526
14. Ziegler, D., Mosier, M., Buenaver, M. & Okuyemi, K. How Much Information bout Adverse Effects of Medication Do Patients Want From Physician? Arch Intern Med, 2001; 161(5): 706-713